These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15111432)

  • 41. Solvent effects on self-assembly of beta-amyloid peptide.
    Shen CL; Murphy RM
    Biophys J; 1995 Aug; 69(2):640-51. PubMed ID: 8527678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxic Amyloid Tape: A Novel Mixed Antiparallel/Parallel β-Sheet Structure Formed by Amyloid β-Protein on GM1 Clusters.
    Okada Y; Okubo K; Ikeda K; Yano Y; Hoshino M; Hayashi Y; Kiso Y; Itoh-Watanabe H; Naito A; Matsuzaki K
    ACS Chem Neurosci; 2019 Jan; 10(1):563-572. PubMed ID: 30346704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular architecture of Aβ fibrils grown in cerebrospinal fluid solution and in a cell culture model of Aβ plaque formation.
    Garvey M; Baumann M; Wulff M; Kumar ST; Markx D; Morgado I; Knüpfer U; Horn U; Mawrin C; Fändrich M; Balbach J
    Amyloid; 2016 Jun; 23(2):76-85. PubMed ID: 26972581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.
    Dammers C; Reiss K; Gremer L; Lecher J; Ziehm T; Stoldt M; Schwarten M; Willbold D
    Biophys J; 2017 Apr; 112(8):1621-1633. PubMed ID: 28445753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
    Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
    Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
    Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into the aggregation mechanism of Aβ(25-40).
    Xiong J; JiJi RD
    Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid α-oligomer formation mediated by the Aβ C terminus initiates an amyloid assembly pathway.
    Misra P; Kodali R; Chemuru S; Kar K; Wetzel R
    Nat Commun; 2016 Aug; 7():12419. PubMed ID: 27546208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.
    Jiang D; Rauda I; Han S; Chen S; Zhou F
    Langmuir; 2012 Sep; 28(35):12711-21. PubMed ID: 22870885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in vitro.
    Jung G; Ryu J; Heo J; Lee SJ; Cho JY; Hong S
    Pharmazie; 2011 Jul; 66(7):529-34. PubMed ID: 21812329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.
    Esler WP; Stimson ER; Jennings JM; Vinters HV; Ghilardi JR; Lee JP; Mantyh PW; Maggio JE
    Biochemistry; 2000 May; 39(21):6288-95. PubMed ID: 10828941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
    Loureiro JA; Rocha S; Pereira Mdo C
    J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's amyloid fibrils: structure and assembly.
    Serpell LC
    Biochim Biophys Acta; 2000 Jul; 1502(1):16-30. PubMed ID: 10899428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
    Mandal PK; Pettegrew JW
    Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible mechanical unzipping of amyloid beta-fibrils.
    Kellermayer MS; Grama L; Karsai A; Nagy A; Kahn A; Datki ZL; Penke B
    J Biol Chem; 2005 Mar; 280(9):8464-70. PubMed ID: 15596431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution.
    Klinger AL; Kiselar J; Ilchenko S; Komatsu H; Chance MR; Axelsen PH
    Biochemistry; 2014 Dec; 53(49):7724-34. PubMed ID: 25382225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of aggregation of synthetic beta-amyloid peptide.
    Tomski SJ; Murphy RM
    Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.